ATE247980T1 - Verwendung von an glycoprotein gpiib/iiia bindenden substanzen zur vermeidung von stenosis und restenosis - Google Patents

Verwendung von an glycoprotein gpiib/iiia bindenden substanzen zur vermeidung von stenosis und restenosis

Info

Publication number
ATE247980T1
ATE247980T1 AT95902460T AT95902460T ATE247980T1 AT E247980 T1 ATE247980 T1 AT E247980T1 AT 95902460 T AT95902460 T AT 95902460T AT 95902460 T AT95902460 T AT 95902460T AT E247980 T1 ATE247980 T1 AT E247980T1
Authority
AT
Austria
Prior art keywords
restenosis
immunoglobulins
iiia
prevent
specific
Prior art date
Application number
AT95902460T
Other languages
English (en)
Inventor
Barry S Coller
Harlan F Weisman
Original Assignee
Centocor Inc
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22523494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE247980(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc, Univ New York State Res Found filed Critical Centocor Inc
Application granted granted Critical
Publication of ATE247980T1 publication Critical patent/ATE247980T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95902460T 1993-11-05 1994-11-07 Verwendung von an glycoprotein gpiib/iiia bindenden substanzen zur vermeidung von stenosis und restenosis ATE247980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14792893A 1993-11-05 1993-11-05
PCT/US1994/012779 WO1995012412A1 (en) 1993-11-05 1994-11-07 Platelet-specific chimeric immunoglobulin and methods of use therefor

Publications (1)

Publication Number Publication Date
ATE247980T1 true ATE247980T1 (de) 2003-09-15

Family

ID=22523494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902460T ATE247980T1 (de) 1993-11-05 1994-11-07 Verwendung von an glycoprotein gpiib/iiia bindenden substanzen zur vermeidung von stenosis und restenosis

Country Status (15)

Country Link
EP (2) EP1334730A3 (de)
JP (1) JPH09504795A (de)
CN (2) CN1140295C (de)
AT (1) ATE247980T1 (de)
AU (2) AU1172495A (de)
CA (1) CA2175214A1 (de)
DE (1) DE69433091T3 (de)
DK (1) DK0725655T4 (de)
ES (1) ES2204937T5 (de)
HK (1) HK1054682B (de)
NZ (2) NZ502819A (de)
PT (1) PT725655E (de)
RU (1) RU2158135C2 (de)
UA (1) UA37249C2 (de)
WO (1) WO1995012412A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
US5753230A (en) † 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
EP0835135A2 (de) * 1995-06-07 1998-04-15 Centocor, Inc. Plättchen-spezifisches, chimäres immunglobulin und verfahren zu seiner verwendung
EP0975368A1 (de) * 1997-02-19 2000-02-02 Centocor, Inc. Arzneimittel mit verzögerter abgabe und zusammensetzung dafür
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
RU2200481C2 (ru) * 2001-02-22 2003-03-20 Научно-Исследовательский Институт Трансплантологии И Искусственных Органов Способ лечения острой сердечной недостаточности
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
RU2240136C1 (ru) * 2003-04-10 2004-11-20 Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н.Габричевского МЗ РФ" Композиция, содержащая иммуноглобулины и целевые добавки

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297815C (en) * 1985-06-07 1992-03-24 Barry S. Coller Fibrinogen blocking monoclonal antibody
CA1297816C (en) * 1985-06-14 1992-03-24 Barry S. Coller Platelet function inhibiting monoclonal antibody fragment
KR940009084B1 (ko) * 1988-05-18 1994-09-29 체크 포인트 시스템스, 인코오퍼레이티드 자기 및 공명회로 검출용 안테나 시스템
ATE124267T1 (de) * 1989-04-03 1995-07-15 Centocor Inc Blutplättchenspezifische immunokonjugate.
CA2120240A1 (en) * 1991-09-30 1993-03-31 Theresa M. Palabrica Inhibition of vascular narrowing using anti-padgen antibodies
DE69232669T2 (de) * 1991-12-20 2003-02-27 Protein Design Labs, Inc. Mit gp11b/iiia reaktive humane antikörper

Also Published As

Publication number Publication date
NZ502819A (en) 2002-09-27
EP1334730A2 (de) 2003-08-13
DK0725655T4 (da) 2009-05-18
PT725655E (pt) 2004-01-30
CN1142189A (zh) 1997-02-05
ES2204937T3 (es) 2004-05-01
WO1995012412A1 (en) 1995-05-11
DE69433091T3 (de) 2009-07-30
NZ527820A (en) 2005-04-29
HK1054682A1 (en) 2003-12-12
JPH09504795A (ja) 1997-05-13
ES2204937T5 (es) 2009-07-06
DE69433091D1 (de) 2003-10-02
DK0725655T3 (da) 2004-01-05
UA37249C2 (uk) 2001-05-15
CA2175214A1 (en) 1995-05-11
RU2158135C2 (ru) 2000-10-27
CN1230201C (zh) 2005-12-07
EP1334730A3 (de) 2003-12-03
HK1054682B (zh) 2006-05-04
EP0725655A1 (de) 1996-08-14
AU8959398A (en) 1999-01-14
DE69433091T2 (de) 2004-06-03
CN1140295C (zh) 2004-03-03
EP0725655B2 (de) 2009-04-15
EP0725655B1 (de) 2003-08-27
AU1172495A (en) 1995-05-23
CN1404877A (zh) 2003-03-26

Similar Documents

Publication Publication Date Title
DE10299038I2 (de) Pl{ttchen-spezifisches Chim{risches immunglobulin.
DE3888186D1 (de) Modulärer zusammenbau von antikörpergenen, dadurch hergestellte antikörper und deren anwendung.
ATE268818T1 (de) Ctla4-mutantmoleküle und deren verwendung
ATE128732T1 (de) Antigenkonstrukte von ''major histocompatibility complex'' klasse i antigenen mit spezifischen trägermolekülen, ihre herstellung und verwendung.
AU1042192A (en) Recombinant antibodies specific for a growth factor receptor
NL300220I1 (nl) Immunoglobuline varianten voor specifieke FC-epsilon receptoren.
EP0325262A3 (en) Cloned genes encoding ig-cd4 fusion proteins and the use thereof
EE04752B1 (et) Monoklonaalne antikeha, seda tootev hübridoom ja antikeha kasutamine
GB9824632D0 (en) Biological compounds
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
DE69433091D1 (de) Verwendung von an Glycoprotein gpIIb/IIIa bindenden Substanzen zur Vermeidung von Stenosis und Restenosis
NO910510D0 (no) Kontrastmiddel oppbygd av polyaldehyder.
DE69624259D1 (de) Vaskulare endothelzelle-wachstumsfaktor antiidotypische antikörper und ihre verwendung als arzneimittel
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
ID20117A (id) Antibodi anti-fas
DE69120452D1 (de) Verwendung und Verabreichung von Enzymen
Wines et al. The Fab/c fragment of IgG produced by cleavage at cyanocysteine residues
UA88604C2 (ru) Применение антитела, которое связывается с альфа-4-интегрином, для лечения демиелинизирующего заболевания

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0725655

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0725655

Country of ref document: EP